Примеры использования Amphetamine-type stimulant на Английском языке и их переводы на Русский язык
{-}
-
Official
-
Colloquial
Control of amphetamine-type stimulants.
Many speakers expressed concern at the high levels of illicit drug manufacture,in particular, the growth in amphetamine-type stimulant manufacture.
Global amphetamine-type stimulant seizures, 2005-2012.
Illicitly manufactured amphetamine-type stimulants.
Global amphetamine-type stimulant seizures, 2006-2011.
Issue 1: reversing the trend of amphetamine-type stimulant abuse.
Amphetamine-type stimulant interdiction worldwide amounted to 38 tons in 2005.
Distribution of seizures of amphetamine-type stimulants, by type, 2008.
Global treatment data from the late 1990s to the period 2007/08 reveals an increasing amount of problematic amphetamine-type stimulant users.
Recommendations on amphetamine-type stimulants and their precursors.
In many countries, there were also many curious combination products,containing various mind-altering substances, including an amphetamine-type stimulant with a barbiturate.
Psychotropic substances, including amphetamine-type stimulants, could be controlled better.
Amphetamine-type stimulant use is thought to be increasing, particularly in Asia, while use of"ecstasy"-group substances seems to have stabilized in all regions.
Cumulative unweighted average of perceived trends in amphetamine-type stimulant use as reported by countries, 2000-2009.
In Bangladesh, seizures of“yaba” amphetamine-type stimulant tablets(pills containing methamphetamine and caffeine) in 2011 rose to their highest levels in the past few years: 1.4 million tablets of“yaba” were seized, compared with a previous high of 800,000 in 2010.
Attempts to use East Africa,predominantly the United Republic of Tanzania, as a diversion point for heroin and amphetamine-type stimulant precursors were also reported in 2016.
A well-developed domestic amphetamine-type stimulant manufacturing capability has shown itself to be adaptive and responsive to demand.
UNODC estimated that, with annual prevalence ranging between 0.3 and 1.3 per cent, between 13.7 million and 56.4 million people aged 15-64 had used an amphetamine-type stimulant at least once in the previous year.
Working Group l:reversing the trend of amphetamine-type stimulant abuse becoming a part of mainstream consumer culture;
It is therefore encouraging that 159 out of 189(84 per cent)of States parties to the 1988 Convention are now providing annual legitimate requirements for at least one of the amphetamine-type stimulant precursors listed in Commission on Narcotic Drugs resolution 49/3.
The proportion of treatment admissions for amphetamine-type stimulant abuse in North America is 16 per cent, compared with 10 per cent in Latin America and the Caribbean.
However, reported seizures of substances classified as"non-specified amphetamines" declined sharply, so thatthe total quantity of amphetamine-type stimulant seizures remained essentially stable at the level in 2006.
In the period 2010-2011, there were 556 detections of amphetamine-type stimulant(excluding MDMA(“ecstasy”)) laboratories and 16 MDMA laboratories were detected, down from 17 in the period 2009-2010.
Such modifications may be determined by the availability of the precursors ormay be the result of a deliberate effort to circumvent legislation by manufacturing an amphetamine-type stimulant not covered by national law or international convention("designer drugs","designer amphetamines" or, more accurately, controlled drug analogues);
There are recent indications that amphetamine-type stimulant use, particularly methamphetamine, may be increasing in the subregion, as more cases of illicit manufacture and trafficking are being reported.
Particularly in recent years, we have observed changes in the nature of this trend,namely that amphetamine-type stimulant drugs are now finding popularity among younger users and are becoming easier to obtain.
Although the annual prevalence of amphetamine-type stimulant use(0.6 per cent of the population aged 15-64) in the subregion remained below the global average, the number of amphetamine-type stimulant users represented a quarter of all estimated users globally.
Although opioids remain the major problem drug, amphetamine-type stimulant treatment demand is increasing, noticeably in South Asia, accounting for 22 per cent of total treatment demand in 2008.
Demand for treatment related to the use of amphetamine-type stimulants was most noticeable in Asia, where they were the second most common primary substances accounting for treatment,while treatment demand for amphetamine-type stimulant use was also substantial in North America, Western and Central Europe and Oceania Australia and New Zealand.
Reference was made to the problem posed by Captagon, an amphetamine-type stimulant, which was being manufactured in Eastern Europe and smuggled into Saudi Arabia through its neighbouring countries or Jordan, the Syrian Arab Republic and Turkey.